Revolution Medicines, Inc.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US76155X1000
USD
162.99
5.22 (3.31%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Nature's Sunshine Products, Inc.
Chromadex Corp.
USANA Health Sciences, Inc.
ProPhase Labs, Inc.
LifeVantage Corp.
Natural Alternatives International, Inc.
Upexi, Inc.
Revolution Medicines, Inc.
Cidara Therapeutics, Inc.
MIRA Pharmaceuticals, Inc.
Bright Green Corp.

Why is Revolution Medicines, Inc. ?

Icon
Unrated Stock - No Analysis Available
stock-recommendationReal-Time Research Report

Verdict Report

Icon
No Data Found

Is Revolution Medicines, Inc. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Revolution Medicines, Inc.
308.19%
4.55
67.96%
S&P 500
25.41%
1.92
13.25%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
-100.00%
EBIT Growth (5y)
-254.07%
EBIT to Interest (avg)
-390.67
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.01
Sales to Capital Employed (avg)
0.01
Tax Ratio
0.11%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
11.24
EV to EBIT
-14.03
EV to EBITDA
-14.23
EV to Capital Employed
-151.57
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-68.41%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Bullish
Bullish
OBV
Bullish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company
NET PROFIT(HY)

Higher at USD -790.29 MM

RAW MATERIAL COST(Y)

Fallen by 0% (YoY

-30What is not working for the Company
INTEREST(9M)

At USD 35.56 MM has Grown at inf%

OPERATING CASH FLOW(Y)

Lowest at USD -1,057.47 MM

ROCE(HY)

Lowest at -76.67%

OPERATING PROFIT(Q)

Lowest at USD -440.69 MM

PRE-TAX PROFIT(Q)

Lowest at USD -438.03 MM

NET PROFIT(Q)

Lowest at USD -438.03 MM

EPS(Q)

Lowest at USD -2.29

Here's what is working for Revolution Medicines, Inc.

Raw Material Cost
Fallen by 0% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Revolution Medicines, Inc.

Interest
At USD 35.56 MM has Grown at inf%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Pre-Tax Profit
At USD -438.03 MM has Fallen at -57.01%
over average net sales of the previous four periods of USD -278.99 MM
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit
At USD -438.03 MM has Fallen at -57.01%
over average net sales of the previous four periods of USD -278.99 MM
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (USD MM)

Operating Cash Flow
Lowest at USD -1,057.47 MM and Fallen
In each year in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)

Operating Profit
Lowest at USD -440.69 MM and Fallen
In each period in the last five periods
MOJO Watch
Near term Operating Profit trend is quite negative

Operating Profit (USD MM)

Pre-Tax Profit
Lowest at USD -438.03 MM and Fallen
In each period in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit
Lowest at USD -438.03 MM and Fallen
In each period in the last five periods
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (USD MM)

EPS
Lowest at USD -2.29
in the last five periods
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (USD)